Avidity of the immunoglobulin g response to a Neissetia meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays

被引:14
作者
Harris, Shannon L.
Tsao, How
Ashton, Lindsey
Goldblatt, David
Fernsten, Philip
机构
[1] Wyeth Vaccines Res, Pearl River, NY 10965 USA
[2] Inst Child Hlth, Immunobiol Unit, London, England
关键词
D O I
10.1128/CVI.00241-06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibody avidity, the strength of the multivalent interaction between antibodies and their antigens, is an important characteristic of protective immune responses. We have developed an inhibition enzyme-linked immunosorbent assay (ELISA) to measure antibody avidity for the capsular polysaccharide (PS) of Neisseria meningitidis group C (MnC) and determined the avidity constants (K(D)s) for 100 sera from children immunized with an MnC PS conjugate vaccine. The avidity constants were compared to the avidity indices (AI) obtained for the same sera using a chaotropic ELISA protocol. After the primary immunization series, the geometric mean (GM) K-D was 674 nM and did not change in the months following immunization. However, the GM avidity did increase after the booster dose (GM K-D, 414 nM 1 month after booster immunization). In contrast, the GM AI increased from an initial value of 118 after the primary immunization series to 147 6 months after the completion of the primary immunization series and then further increased to 178 after booster immunization. At the individual subject level, the avidity constant and AI correlated after the primary immunization series and after booster immunization but not prior to boosting. This work suggests that the AI, as measured by the chaotropic ELISA, in contrast to the K-D, reflects changes that render antibody populations less susceptible to disruption by chaotropic agents without directly affecting the strength of the binding interactions.
引用
收藏
页码:397 / 403
页数:7
相关论文
共 34 条
[1]  
Anttila M, 1999, CLIN EXP IMMUNOL, V118, P402
[2]   Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines [J].
Anttila, M ;
Eskola, J ;
Åhman, H ;
Käyhty, H .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06) :1614-1621
[3]   Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood [J].
Anttila, M ;
Eskola, J ;
Åhman, H ;
Käyhty, H .
VACCINE, 1999, 17 (15-16) :1970-1977
[4]   Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United Kingdom [J].
Borrow, R ;
Goldblatt, D ;
Finn, A ;
Southern, J ;
Ashton, L ;
Andrews, N ;
Lal, G ;
Riley, C ;
Rahim, R ;
Cartwright, K ;
Allan, G ;
Miller, E .
INFECTION AND IMMUNITY, 2003, 71 (10) :5549-5555
[5]   Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom [J].
Borrow, R ;
Goldblatt, D ;
Andrews, N ;
Southern, J ;
Ashton, L ;
Deane, S ;
Morris, R ;
Cartwright, K ;
Miller, E .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (09) :1353-1357
[6]   Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children [J].
Borrow, R ;
Goldblatt, D ;
Andrews, N ;
Richmond, P ;
Southern, J ;
Miller, E .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (03) :377-380
[7]   Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: Reevaluation of correlates of protection [J].
Borrow, R ;
Andrews, N ;
Goldblatt, D ;
Miller, E .
INFECTION AND IMMUNITY, 2001, 69 (03) :1568-1573
[8]   AN ANALYSIS OF TRANSFORMATIONS [J].
BOX, GEP ;
COX, DR .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1964, 26 (02) :211-252
[9]  
BUNDLE DR, 1994, METHOD ENZYMOL, V247, P288
[10]   Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection [J].
Burrage, M ;
Robinson, A ;
Borrow, R ;
Andrews, N ;
Southern, J ;
Findlow, J ;
Martin, S ;
Thornton, C ;
Goldblatt, D ;
Corbel, M ;
Sesardic, D ;
Cartwight, K ;
Richmond, P ;
Miller, E .
INFECTION AND IMMUNITY, 2002, 70 (09) :4946-4954